… claim for apixaban, dabigatran, rivaroxaban, or warfarin from … approve their use in the
management of NVAF. Furthermore, … patient stroke risk, physician overestimation of bleeding risk, …

… of patients treated with a low dose of dabigatran resulted in … In summary, apixaban,
rivaroxaban, and dabigatran appear to … number of non-valvular AF patients on NOACs or warfarin. …

… Dabigatran, rivaroxaban, or edoxaban were used at lower doses, while apixaban was used
at standard dose in patients with atrial … , especially with the use of warfarin. Asians have a …

… which warfarin, dabigatran, apixaban, edoxaban or rivaroxaban … a lower risk of haemorrhage
than that for warfarin; moreover, … Any product that may be evaluated in this article, or claim …

… 65 low-dose (30mg once-daily) edoxaban with VKAs in AF … edoxaban 96 treatment in
non-valvular AF patients, and (2) … risks of SSE with apixaban, 251 rivaroxaban, and dabigatran …

… the risk of MB, low-dose DOACs, generally rivaroxaban 15mg or … risk of TE and MB versus
warfarin; (2) Compared to warfarin, non-… Apixaban in patients at risk of stroke undergoing atrial …

… Bleeding risk of apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in
Japanese patients … of administrative claims data. Curr Med Res Opin 2017;33:1955–63. [12…

… DOACs (apixaban, rivaroxaban, dabigatran) vs warfarin, Cox … Loire Valley Non-valvular AF
Project and studied 8,962 patients (… of low dose DOACs in patients with a high risk of bleeding …

… (dabigatran, rivaroxaban and apixaban) or warfarin in the year following hospitalization, but
could not have used any OAC one year prior to this claim. … bleeds among warfarin, low dose …

… of factor Xa (apixaban, edoxaban, and rivaroxaban) or of thrombin (dabigatran). RCTs have
… Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: do …